October is recognized by SAMHSA as Substance Use and Misuse Prevention Month, a reminder that prevention and treatment succeed only when patients feel safe engaging with care. In nearly every care setting, from the emergency department to the family practice clinic, nurse practitioners encounter patients living with substance use disorders. Yet stigma remains the invisible variable that still determines who gets screened, who gets offered treatment, and who feels welcome to return. Stigma has become not just a social problem, but a structural determinant of health.
How Stigma Shapes Clinical Outcomes
Stigma around substance use disorders operates at every level. At the institutional level, stigma is built into policy: rigid discharge rules for patients who use drugs, lack of funding for addiction programs, or EHRs that flag certain behaviors as “drug-seeking.” At the interpersonal level, stigma is perpetuated through dehumanizing language that paints substance use as a moral failing rather than a medical issue. Patients absorb and internalize perceived judgments from peers and clinicians, leading to shame, isolation, and concealment of use.
The Ontario Public Health framework on health-related stigma describes how these levels intersect with other social inequities, such as race, gender, and socioeconomic status, to compound harm. A person already marginalized by poverty or homelessness experiences additive stigma when substance use is layered on top. The result is poorer access, worse outcomes, and lower quality care.
CDC data illustrate the impact starkly. In 2022, 54.6 million Americans met criteria for a substance use disorder, but only 13.1 million received treatment. Fear of judgment leads many to hide their use or forego treatment, which can lead to relapsing or even overdose. Despite this, many healthcare professionals still do not view SUD as a chronic illness like diabetes or heart disease. That misunderstanding shapes how care is delivered: patients with SUD are more likely to be denied services, receive substandard pain control, or face punitive policies for missed appointments or return to use. Each missed opportunity amplifies the cycle of harm.
Why NPs Must Lead the Charge
Nurse practitioners sit at the intersection of clinical care and human connection. Their training emphasizes whole-person assessment and patient education, tools that make stigma reduction a clinical competency.
A position paper in the Journal of Academic Nursing led by Zhanette Coffee, Ph.D., MSN, APRN, highlighted how empowering NPs to manage opioid use disorder expanded access to care and reframed the tone of treatment conversations. Patients reported higher trust and lower fear of judgment in NP-led programs.
NPs are also system builders: They write notes, develop protocols, teach students, and often lead interdisciplinary teams. Each of those touchpoints is a chance to normalize non-stigmatizing practice.
Practical Ways to Reduce Stigma in Clinical Practice
Make neutral language the default. Words matter when it comes to SUD treatment. For example, swap “noncompliant” with “treatment interrupted.” Avoid pointed terms like “addict” or “dirty screen.” Instead, describe behavior factually (“urine toxicology positive for amphetamines; patient reports occasional use”). The National Institute on Drug Abuse (NIDA) maintains a guide for clinicians on destigmatizing language, which can be found here. The CDC also provides phrasing examples.
Treat substance use like any other chronic condition. Normalize screening for SUD as routine preventive care. Ask about alcohol, tobacco, and other substance use the same way vital signs are recorded. Framing SUD as a medical condition, not a moral failure, signals safety and encourages disclosure.
Explain safety policies upfront. Framing PDMP checks and toxicology screens as universal safety steps (“used for everyone receiving controlled meds”) reduces defensiveness and increases honest disclosure over time. CDC resources emphasize that transparency is protective, not permissive.
Build non-punitive re-engagement pathways. Early instability is common across SUDs, and patients commonly cycle in and out of care. Setting expectations (for example, “If use returns, come back; we’ll adjust the plan”) reduces shame and keeps contact intact. Non-punitive re-engagement policies improve treatment adherence and safety.
Integrate brief harm-reduction counseling. Two minutes is enough to cover overdose recognition and naloxone use, safer‑use basics (avoid using alone; know local testing resources where lawful; avoiding mixing depressants, etc.), and a concrete plan for follow‑up.
Name bias out loud. In team huddles or precepting settings, correct stigmatizing language when it occurs. Reframing comments (e.g. “Let’s describe the behavior, not the person”) creates peer accountability.
Building Team and System Habits That Stick
Individual skill is necessary in tackling substance use stigma in clinical settings, but institutional design determines sustainability. Evidence from Columbia University’s stigma-reduction program suggests the most effective interventions are multi-component: staff training paired with contact with people with lived experience, policy revision, and reflective supervision.
NPs can lead these efforts in a number of ways. For example, ensuring that quality metrics for SUD care (screening, referral, follow-up) are tracked like other chronic diseases normalizes SUD treatment like that of any other disease. Partnering with community organizations to bring recovery voices into staff education can humanize patients with SUDs. At scale, these actions turn stigma reduction from personal intention into institutional practice.
The Clinical Case for Compassion
Reducing stigma is part of SUD treatment, not ancillary to it. Compassion improves adherence, continuity, and safety outcomes across chronic illnesses, and SUD is no different. For nurse practitioners, the opportunity is profound. Each commitment to reducing stigma rewrites how the healthcare system treats one of its most vulnerable populations. That shift is how the profession closes the gap between what’s known about SUD treatment and the care patients receive.
